Statement of Practice Summary:
General Practice. Alternative Dispute Resolution; Antitrust; Appellate Litigation and Legal Issues; Banking and Institutional Investing; Communications; Complex Mass Torts and Insurance Litigation; Consumer Financial Services Enforcement and Litigation; Corporate; Corporate Compliance Programs; Corporate Finance; Corporate Governance; Corporate Restructuring; Derivative Financial Products, Commodities and Futures; Employee Benefits and Executive Compensation; Energy Project Finance and Development; Energy Regulatory; Environmental; Environmental Litigation; European Union/International Competition; Financial Institutions; Financial Services ; Franchise Law; Gaming; Government Contract Disputes; Government Enforcement Litigation; Health Care; Health Care Enforcement and Litigation; Health Care Fraud and Abuse; Information Technology and E-Commerce; Insurance; Intellectual Property and Technology; International Arbitration; International Law and Policy; International Tax; International Trade; Investment Management; Labor and Employment; Lease Financing; Litigation; Mergers and Acquisitions; Outsourcing; Patent and Technology Litigation and Counseling; Pharmaceutical, Biotechnology and Medical Device Licensing; Political Law; Private Equity; Private Investment Funds; Privatizations; Products Liability; Public Policy; Real Estate; Real Estate Investment Trusts; Securities Enforcement and Compliance; Securities Litigation; Sports; Structured Finance; Tax; Tax Controversy and Litigation; Trademark, Copyright, and Advertising Litigation and Counseling; Trusts and Estates; Uniformed Commercial Code and Secured Transactions; Utilities Mergers and Acquisitions; White Collar Crime.
Documents by Lawyers at this office
FTC Doubles Down in Challenge to Pharmaceutical Settlement
Paul M. Eckles,Karen Hoffman Lent,Sharis A. Pozen,Steven C. Sunshine, September 15, 2014
On September 8, 2014, the Federal Trade Commission (FTC) filed a federal antitrust complaint in the United States District Court for the Eastern District of Pennsylvania against defendants AbbVie, Abbott Laboratories, Unimed Pharmaceuticals, Besins Healthcare and Teva Pharmaceuticals alleging...
Structured Finance Alert: SEC Adopts Final Regulation AB II Rules
Andrew M. Faulkner,Richard F. Kadlick,David H. Midvidy,James S. Stringfellow,Eva N. Valik, September 4, 2014
On August 27, 2014, the Securities and Exchange Commission ("SEC") adopted final rules ("ABS Final Rules") that significantly revise the existing regulations that govern disclosure requirements, offering processes and periodic reporting for asset-backed securities (commonly...
Year Established: 1948
(For biographical data on other personnel, see firm's other Professional Biographies)